Glandular fever test procedures identify infection with the Epstein-Barr virus, helping clinicians confirm infectious mononucleosis. Rapid recognition of symptoms and appropriate testing reduce the risk of complications or misdiagnosis.
Understanding how these tests work, what the results mean, and how to prepare supports more confident decision making for both patients and clinicians. The following sections outline key aspects of testing in a practical, easy to scan format.
| Test Type | Sample Required | Result Turnaround | Main Use |
|---|---|---|---|
| Monospot test | Whole blood or plasma | 15–30 minutes | Quick screening for heterophile antibodies |
| EBV serology panel | Blood serum | 1–3 days | Confirmatory detection of specific EBV antibodies |
| PCR for EBV DNA | Plasma or saliva | 2–5 days | Quantify viral load in immunocompromised patients |
| Complete blood count | Blood sample | Same day | Assess atypical lymphocytes and rule out other causes |
Recognizing Symptoms That Justify Testing
Persistent fever, severe fatigue, sore throat, and swollen lymph nodes often prompt a glandular fever test. Early identification limits unnecessary antibiotic use and clarifies the infectious cause.
Physical Signs and Differential Concerns
Clinicians note splenomegaly, hepatomegaly, or rash when evaluating glandular fever. Because these features can overlap with other infections, targeted testing helps confirm Epstein-Barr virus involvement.
How the Monospot Test Works
The Monospot test detects heterophile antibodies produced during acute Epstein-Barr infection. It is commonly used in outpatient settings for rapid decision support.
Performance and Limitations
Sensitivity is highest in adolescents and adults, with lower results in young children. False negatives may appear early in infection, requiring repeat testing or EBV serology.
EBV Serology for Confirmation
An EBV serology panel measures antibodies against viral capsid antigen, early antigen, and nuclear antigen. This pattern clarifies current, past, or reactivated infection.
Interpreting Antibody Profiles
AntiVCA IgM positive with antiEBNA negative suggests recent infection. AntiEBNA positivity indicates past infection, while fluctuating antiEA levels may signal reactivation.
Specimen Collection and Timing
Clinicians collect serum or plasma for most tests, while saliva is useful for PCR in certain cases. Proper timing improves accuracy and reduces repeat sampling.
- Collect serum samples within the first week of symptoms for optimal antibody detection
- Avoid unnecessary repeat testing when initial Monospot and clinical findings align
- Consider PCR in immunocompromised patients where serology may be unreliable
- Document clinical symptoms to guide test selection and interpretation
Clinical Decisions Based on Test Results
Results from a glandular fever test guide activity restrictions, follow up schedules, and complication monitoring. Clear communication between patients and clinicians supports safer recovery and long term management. Tailored use of testing optimizes diagnosis while minimizing unnecessary procedures.
FAQ
Reader questions
Can a Monospot test be negative even if I have glandular fever?
Yes, especially in children under ten or early in illness; repeat testing or EBV serology may clarify the diagnosis.
How long after exposure should I get tested for EBV?
Symptoms often appear four to six weeks post exposure, and testing after this window improves detection of antibodies.
Will a positive test mean I need antibiotics for glandular fever?
No, antibiotics are not effective against Epstein-Barr virus; testing helps avoid unnecessary treatment and guides supportive care.
Is EBV PCR more accurate than the Monospot test for adults?
PCR is highly sensitive for viral DNA but is typically reserved for cases where serology is unclear or in immunocompromised patients.